Hematology Laboratory Shift Based on Common Terminology Criteria in Patients With Advanced Basal Cell Carcinoma Receiving Sonidegib 200 Mg Daily: Results from the 42-Month BOLT Study. J of Skin 2023, 7 (2), s180. https://doi.org/10.25251/skin.7.supp.180.